Form 8-K Provention Bio, Inc. For: May 27
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Provention Bio Inc. (PRVB) PT Lowered to $22.50 at Chardan Capital Markets Following FDA AdComm Vote
May 28, 2021 9:29 AM EDTChardan Capital Markets analyst Gbola Amusa lowered the price target on Provention Bio Inc. (NASDAQ: PRVB) to $22.50 (from $35.00) while maintaining a Buy rating following the FDA Advisory Committee vote.
The analyst commented, "Provention Bio (Buy): Yesterday, the FDA Advisory Committee (EMDAC)... More
Provention Bio Inc. (PRVB) to Resume Trading at 7:10 a.m.
May 28, 2021 7:08 AM EDTProvention Bio Inc. (NASDAQ: PRVB) to Resume Trading at 7:10 a.m.
